SCIESCOPUSQ1
Blood Cancer Discovery
AMER ASSOC CANCER RESEARCH, United States
Blood Cancer Discovery is an academic journal published by AMER ASSOC CANCER RESEARCH (United States). Identifiers: ISSN 2643-3230, eISSN 2643-3249. Indexed in SCIE, SCOPUS. Metrics: JIF 11.5, CiteScore 15.8, SJR 4.316, SNIP 1.48. Subject areas: ONCOLOGY. tlooto lists 608 papers from this journal.
CiteScore
15.80
Scopus citation metric
SJR
4.316
SCImago rank
SNIP
1.48
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 2643-3230
- eISSN
- 2643-3249
- Abbreviation
- BLOOD CANCER DISCOV
- Publisher
- AMER ASSOC CANCER RESEARCH
- Country
- United States
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
1301 Biochemistry1306 Cancer Research2720 Hematology2730 Oncology
Papers in this journal
Recent papers
- Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models.
2026 · 1 citations
- Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed/Refractory Multiple Myeloma
2026
- Ibrutinib with venetoclax in patients with relapsed/refractory chronic lymphocytic leukemia: A phase II study.
2026
- Incorporating ALL Biology into Treatment Decisions: Next Steps toward Targeted Therapy in Adult ALL.
2026
- First-line Therapy in Newly Diagnosed Multiple Myeloma.
2026
Most cited papers
- Scalable Manufacturing of CAR T cells for Cancer Immunotherapy.
2021 · 210 citations
- Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma
2020 · 177 citations
- Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia
2021 · 139 citations
- A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies.
2023 · 126 citations
- Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia
2020 · 123 citations